HRT Financial’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,373
Closed -$13K 3333
2024
Q4
$13K Buy
+1,373
New +$13K ﹤0.01% 2043
2023
Q1
Sell
-2,088
Closed -$246K 3118
2022
Q4
$246K Buy
+2,088
New +$246K ﹤0.01% 1673
2022
Q3
Sell
-1,893
Closed -$169K 3461
2022
Q2
$169K Buy
1,893
+1,291
+214% +$115K ﹤0.01% 2227
2022
Q1
$93K Buy
+602
New +$93K ﹤0.01% 2409
2021
Q3
Sell
-3,486
Closed -$1.58M 3615
2021
Q2
$1.58M Buy
+3,486
New +$1.58M 0.01% 705